Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial - Pignata, S; Scambia, G; Katsaros, D (Lancet Oncol, 2014)